Image For Activity Cover
Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years' Experience Provides Guidance for Management - JCEP March 2022
Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years' Experience Provides Guidance for Management - JCEP March 2022
LCSD is still underutilized because clinicians are often uncertain whether to use it versus an implantable cardioverter defibrillator (ICD). We provide definitive evidence for the long-term efficacy of LCSD in LQTS. The degree of antiarrhythmic protection is influenced by patient's specificity and amount of QTc shortening. This novel approach to the analysis of the outcome allows cardiologists to rationally decide and tailor their management strategies to the individual features of their patients. 


Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC 

CME Editor
Kenneth A. Ellenbogen, MD

Author
Kenneth A. Ellenbogen, MD

Important Dates
Date of Release: March 21, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: March 20, 2023
Summary
Availability: On-Demand
Expires on Mar 20, 2023
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By